Up-regulation of brain-derived neurotrophic factor in primary afferent pathway regulates colon-to-bladder cross-sensitization in rat

Journal of Neuroinflammation

Li-Ya Qiao³  Hamid I Akbarali²  John F Kuemmerle¹  Karnam S Murthy¹  John R Grider¹  Sharon J Yu³  Melisa A Gulick³  Chun-Mei Xia³ 

[1] Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia;Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia;Departments of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, 1220 East Broad Street, PO Box 0551, MMRB 5038, VA 23219 Richmond, Virginia

关键词: Bladder;    Colon;    Cross-sensitization;    Afferents;    BDNF;   

Others  :  1212809
DOI  :  10.1186/1742-2094-9-30

 received in 2011-09-19, accepted in 2012-02-15,  发布年份 2012

【 摘 要 】

Background

In humans, inflammation of either the urinary bladder or the distal colon often results in sensory cross-sensitization between these organs. Limited information is known about the mechanisms underlying this clinical syndrome. Studies with animal models have demonstrated that activation of primary afferent pathways may have a role in mediating viscero-visceral cross-organ sensitization.

Methods

Colonic inflammation was induced by a single dose of tri-nitrobenzene sulfonic acid (TNBS) instilled intracolonically. The histology of the colon and the urinary bladder was examined by hematoxylin and eosin (H&E) stain. The protein expression of transient receptor potential (TRP) ion channel of the vanilloid type 1 (TRPV1) and brain-derived neurotrophic factor (BDNF) were examined by immunohistochemistry and/or western blot. The inter-micturition intervals and the quantity of urine voided were obtained from analysis of cystometrograms.

Results

At 3 days post TNBS treatment, the protein level of TRPV1 was increased by 2-fold (p < 0.05) in the inflamed distal colon when examined with western blot. TRPV1 was mainly expressed in the axonal terminals in submucosal area of the distal colon, and was co-localized with the neural marker PGP9.5. In sensory neurons in the dorsal root ganglia (DRG), BDNF expression was augmented by colonic inflammation examined in the L1 DRG, and was expressed in TRPV1 positive neurons. The elevated level of BDNF in L1 DRG by colonic inflammation was blunted by prolonged pre-treatment of the animals with the neurotoxin resiniferatoxin (RTX). Colonic inflammation did not alter either the morphology of the urinary bladder or the expression level of TRPV1 in this viscus. However, colonic inflammation decreased the inter-micturition intervals and decreased the quantities of urine voided. The increased bladder activity by colonic inflammation was attenuated by prolonged intraluminal treatment with RTX or treatment with intrathecal BDNF neutralizing antibody.

Conclusion

Acute colonic inflammation increases bladder activity without affecting bladder morphology. Primary afferent-mediated BDNF up-regulation in the sensory neurons regulates, at least in part, the bladder activity during colonic inflammation.

【 授权许可】

   
2012 Xia et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM: Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997, 49:52-57.
• [2]Banner MP: Genitourinary complications of inflammatory bowel disease. Radiol Clin North Am 1987, 25:199-209.
• [3]Ben-Ami H, Ginesin Y, Behar DM, Fischer D, Edoute Y, Lavy A: Diagnosis and treatment of urinary tract complications in Crohn's disease: an experience over 15 years. Can J Gastroenterol 2002, 16:225-229.
• [4]Manganiotis AN, Banner MP, Malkowicz SB: Urologic complications of Crohn's disease. Surg Clin North Am 2001, 81:197-215.
• [5]Shield DE, Lytton B, Weiss RM, Schiff M Jr: Urologic complications of inflammatory bowel disease. J Urol 1976, 115:701-706.
• [6]Bielefeldt K, Lamb K, Gebhart GF: Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2006, 291:G658-G665.
• [7]Lamb K, Zhong F, Gebhart GF, Bielefeldt K: Experimental colitis in mice and sensitization of converging visceral and somatic afferent pathways. Am J Physiol Gastrointest Liver Physiol 2006, 290:G451-G457.
• [8]Zhou Q, Price DD, Caudle RM, Verne GN: Visceral and somatic hypersensitivity in a subset of rats following TNBS-induced colitis. Pain 2008, 134:9-15.
• [9]Miranda A, Peles S, Shaker R, Rudolph C, Sengupta JN: Neonatal nociceptive somatic stimulation differentially modifies the activity of spinal neurons in rats and results in altered somatic and visceral sensation. J Physiol 2006, 572:775-787.
• [10]Peles S, Miranda A, Shaker R, Sengupta JN: Acute nociceptive somatic stimulus sensitizes neurones in the spinal cord to colonic distension in the rat. J Physiol 2004, 560:291-302.
• [11]Pezzone MA, Liang R, Fraser MO: A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 2005, 128:1953-1964.
• [12]Ustinova EE, Fraser MO, Pezzone MA: Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol 2006, 290:1478-1487.
• [13]Brumovsky PR, Feng B, Xu L, McCarthy CJ, Gebhart GF: Cystitis increases colorectal afferent sensitivity in the mouse. Am J Physiol Gastrointest Liver Physiol 2009, 297:G1250-G1258.
• [14]Brumovsky PR, Gebhart GF: Visceral organ cross-sensitization - an integrated perspective. Auton Neurosci 2010, 153:106-115.
• [15]Malykhina AP: Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 2007, 149:660-672.
• [16]Ustinova EE, Fraser MO, Pezzone MA: Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn 2010, 29:77-81.
• [17]Ustinova EE, Gutkin DW, Pezzone MA: Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides. Am J Physiol Renal Physiol 2007, 292:F123-F130.
• [18]Malykhina AP, Qin C, Foreman RD, Akbarali HI: Colonic inflammation increases Na + currents in bladder sensory neurons. NeuroReport 2004, 15:2601-2605.
• [19]Qiao LY, Grider JR: Up-regulation of calcitonin gene-related peptide and receptor tyrosine kinase TrkB in rat bladder afferent neurons following TNBS colitis. Exp Neurol 2007, 204:667-679.
• [20]Qin C, Malykhina AP, Akbarali HI, Foreman RD: Cross-organ sensitization of lumbosacral spinal neurons receiving urinary bladder input in rats with inflamed colon. Gastroenterology 2005, 129:1967-1978.
• [21]De Schepper HU, De Winter BY, Van Nassauw L, Timmermans JP, Herman AG, Pelckmans PA, De Man JG: TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats. J Physiol 2008, 586:5247-5258.
• [22]Jones RC, Xu L, Gebhart GF: The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 2005, 25:10981-10989.
• [23]Malin SA, Christianson JA, Bielefeldt K, Davis BM: TPRV1 expression defines functionally distinct pelvic colon afferents. J Neurosci 2009, 29:743-752.
• [24]Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta JN: The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 2007, 148:1021-1032.
• [25]Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ: The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007, 132:615-627.
• [26]Yu L, Yang F, Luo H, Liu FY, Han JS, Xing GG, Wan Y: The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant. Mol Pain 2008, 4:61-71. BioMed Central Full Text
• [27]Craft RM, Cohen SM, Porreca F: Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain 1995, 61:317-323.
• [28]Cruz F, Guimaräes M, Silva C, Reis M: Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 1997, 350:640-641.
• [29]Dray A, Bettaney J, Forster P: Resiniferatoxin, a potent capsaicinlike stimulator of peripheral nociceptors in the neonatal rat tail in vitro. Br J Pharmacol 1990, 99:323-326.
• [30]Szallasi A, Joo F, Blumberg PM: Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog. Brain Res 1989, 503:68-72.
• [31]Mozsik G, Vincze A, Szolcsanyi J: Four response stages of capsaicin-sensitive primary afferent neurons to capsaicin and its analog: gastric acid secretion, gastric mucosal damage and protection. J Gastroenterol Hepatol 2001, 16:1093-1097.
• [32]Chen TY, Corcos J, Camel M, Ponsot Y, le Tu M: Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct 2005, 16:293-297.
• [33]Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, Perez-Marrero R, Jacoby K, Diokno AC, O'Reilly KJ, Griebling TL, Vasavada SP, Yu AS, Frumkin LR: Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005, 173:1590-1594.
• [34]Qiao LY, Grider JR: Colitis elicits differential changes in the expression levels of receptor tyrosine kinase TrkA and TrkB in colonic afferent neurons: a possible involvement of axonal transport. Pain 2010, 151:117-127.
• [35]Cho HJ, Kim JK, Zhou XF, Rush RA: Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res 1997, 764:269-272.
• [36]Mannion RJ, Costigan M, Decosterd I, Amaya F, Ma QP, Holstege JC, Ji RR, Acheson A, Lindsay RM, Wilkinson GA, Woolf CJ: Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 1999, 96:9385-9390.
• [37]Qiao LY, Gulick MA, Bowers J, Kuemmerle JF, Grider JR: Differential changes in brain-derived neurotrophic factor and extracellular signal-regulated kinase in rat primary afferent pathways with colitis. Neurogastroenterol Motil 2008, 20:928-938.
• [38]Groth R, Aanonsen L: Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia. Pain 2002, 100:171-181.
• [39]Matayoshi S, Jiang N, Katafuchi T, Koga K, Furue H, Yasaka T, Nakatsuka T, Zhou XF, Kawasaki Y, Tanaka N, Yoshimura M: Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat. J Physiol 2005, 569:685-695.
• [40]Delafoy L, Gelot A, Ardid D, Eschalier A, Bertrand C, Doherty AM, Diop L: Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut 2006, 55:940-945.
• [41]Yang J, Yu Y, Yu H, Zuo X, Liu C, Gao L, Chen ZY, Li Y: The role of brain-derived neurotrophic factor in experimental inflammation of mouse gut. Eur J Pain 2010, 14:574-579.
• [42]Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH: BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 2008, 105:2711-2716.
• [43]Li WP, Xian C, Rush RA, Zhou XF: Upregulation of brain-derived neurotrophic factor and neuropeptide Y in the dorsal ascending sensory pathway following sciatic nerve injury in rat. Neurosci Lett 1999, 260:49-52.
• [44]Zhou XF, Rush RA: Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience 1996, 74:945-953.
• [45]di Mola FF, Friess H, Zhu ZW, Koliopanos A, Bley T, Di Sebastiano P, Innocenti P, Zimmermann A, Büchler MW: Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 2000, 46:670-679.
• [46]Sharkey KA, Kroese AB: Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat Rec 2001, 262:79-90.
• [47]Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestley JV: Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 1997, 17:8476-8490.
• [48]Applebaum AE, Vance WH, Coggeshall RE: Segmental localization of sensory cells that innervate the bladder. J Comp Neurol 1980, 192:203-209.
• [49]Keast JR, de Groat WC: Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J Comp Neurol 1992, 319:615-623.
• [50]Berthoud HR, Blackshaw LA, Brookes SJ, Grundy D: Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004, 16:(Suppl 1):28-33.
• [51]Robinson DR, McNaughton PA, Evans ML, Hicks GA: Characterization of the primary spinal afferent innervation of the mouse colon using retrograde labeling. Neurogastroenterol Motil 2004, 16:113-124.